SG11202007544RA - Water soluble salts of lipidated peptides and methods for preparing and using the same - Google Patents
Water soluble salts of lipidated peptides and methods for preparing and using the sameInfo
- Publication number
- SG11202007544RA SG11202007544RA SG11202007544RA SG11202007544RA SG11202007544RA SG 11202007544R A SG11202007544R A SG 11202007544RA SG 11202007544R A SG11202007544R A SG 11202007544RA SG 11202007544R A SG11202007544R A SG 11202007544RA SG 11202007544R A SG11202007544R A SG 11202007544RA
- Authority
- SG
- Singapore
- Prior art keywords
- preparing
- methods
- same
- water soluble
- soluble salts
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862636552P | 2018-02-28 | 2018-02-28 | |
PCT/KR2019/002397 WO2019168357A1 (en) | 2018-02-28 | 2019-02-27 | Water soluble salts of lipidated peptides and methods for preparing and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202007544RA true SG11202007544RA (en) | 2020-09-29 |
Family
ID=67684306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202007544RA SG11202007544RA (en) | 2018-02-28 | 2019-02-27 | Water soluble salts of lipidated peptides and methods for preparing and using the same |
Country Status (9)
Country | Link |
---|---|
US (1) | US11739120B2 (en) |
EP (1) | EP3759070A4 (en) |
JP (2) | JP7104141B2 (en) |
KR (1) | KR102058853B1 (en) |
CN (1) | CN110959002A (en) |
PH (1) | PH12020551233A1 (en) |
SG (1) | SG11202007544RA (en) |
TW (2) | TWI811767B (en) |
WO (1) | WO2019168357A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102104507B1 (en) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same |
CN111297905B (en) * | 2020-03-18 | 2022-11-04 | 四川大学华西医院 | Skin precursor cell-based extract and preparation method and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1195762B (en) * | 1980-10-13 | 1988-10-27 | Reiner Alberto Real Sas | WATER SOLUBLE DERIVATIVES OF CEPHALEXIN AND PROCEDURE FOR THEIR PRODUCTION |
DE3839127A1 (en) | 1988-11-19 | 1990-05-23 | Hoechst Ag | PYRROLIDONE-2-CARBONIC ACID DERIVATIVES WITH PSYCHOTROPER EFFECT |
AUPM906594A0 (en) | 1994-10-26 | 1994-11-17 | Peptide Technology Limited | Synthetic polyunsaturated fatty acid analogues |
PT923555E (en) | 1996-05-01 | 2005-09-30 | Ortho Mcneil Pharm Inc | DERIVATIVES CARBOXAMIDE OF PYRROLIDINE, PIPERIDINE AND HEXA-HYDROAZEPINE FOR THE TREATMENT OF TROMBOTIC DISTURBLES |
DE69915004T2 (en) | 1998-11-05 | 2004-09-09 | Pfizer Products Inc., Groton | 5-Oxo-pyrrolidine-2-carboxylic acid Hydroxamidderivate |
WO2003007876A2 (en) | 2001-06-25 | 2003-01-30 | University Of Massachusetts | N-fatty acid-amino acid conjugates and therapeutic uses |
US20060252698A1 (en) | 2005-04-20 | 2006-11-09 | Malcolm Bruce A | Compounds for inhibiting cathepsin activity |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
MX2010002300A (en) * | 2007-08-29 | 2010-03-18 | Pfizer Prod Inc | Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl ) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same. |
WO2010059922A1 (en) * | 2008-11-21 | 2010-05-27 | Ligand Pharmaceuticals Incorporated | Pyrrolidine carboxamide compounds |
KR101151878B1 (en) | 2010-06-08 | 2012-05-31 | 미원상사주식회사 | Fatty Acid Tripeptide Salt and Antimicrobial Composition Containing the Same |
KR101348284B1 (en) | 2010-09-09 | 2014-01-03 | 주식회사 나이벡 | Combination of Human derived Cell Permeable Peptide and Bioactive Peptide (TOPscovery) and Use Thereof |
KR20120048864A (en) | 2010-11-08 | 2012-05-16 | 주식회사 네오디엠 | A method for preparing the preventive and therapeutic compositions for atopic dermatitis |
KR20130038426A (en) | 2011-10-07 | 2013-04-18 | 성균관대학교산학협력단 | Glycol chitosan hydrogel modified hydrophobically with fatty acid-bonded antidiabetic peptide and a pharmaceutical composition for prevention or treatment of diabetes comprising the same |
KR101359886B1 (en) | 2011-12-28 | 2014-02-12 | 성균관대학교산학협력단 | Composition for treating sepsis or septic shock comprising the Peptide originated from the Smad6 |
US20150368197A1 (en) * | 2012-06-21 | 2015-12-24 | Radikal Therapeutics Ins. | Compositions and methods for treatment of inflammatory diseases of the lung |
CN103724204B (en) * | 2013-11-27 | 2016-05-11 | 北京化工大学 | A kind of water soluble starter and preparation |
PT3265443T (en) * | 2015-07-08 | 2020-02-14 | Korea Res Inst Chemical Tech | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
-
2019
- 2019-02-27 TW TW110130498A patent/TWI811767B/en active
- 2019-02-27 TW TW108106759A patent/TWI762770B/en active
- 2019-02-27 SG SG11202007544RA patent/SG11202007544RA/en unknown
- 2019-02-27 EP EP19759922.8A patent/EP3759070A4/en active Pending
- 2019-02-27 CN CN201980003752.4A patent/CN110959002A/en active Pending
- 2019-02-27 KR KR1020190023508A patent/KR102058853B1/en active IP Right Grant
- 2019-02-27 WO PCT/KR2019/002397 patent/WO2019168357A1/en unknown
- 2019-02-27 JP JP2020505847A patent/JP7104141B2/en active Active
- 2019-02-28 US US16/288,571 patent/US11739120B2/en active Active
-
2020
- 2020-08-10 PH PH12020551233A patent/PH12020551233A1/en unknown
-
2022
- 2022-04-15 JP JP2022067393A patent/JP2022106788A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2020529435A (en) | 2020-10-08 |
EP3759070A4 (en) | 2021-12-08 |
CN110959002A (en) | 2020-04-03 |
WO2019168357A1 (en) | 2019-09-06 |
KR102058853B1 (en) | 2019-12-24 |
JP2022106788A (en) | 2022-07-20 |
TW202222818A (en) | 2022-06-16 |
TWI811767B (en) | 2023-08-11 |
EP3759070A1 (en) | 2021-01-06 |
TWI762770B (en) | 2022-05-01 |
JP7104141B2 (en) | 2022-07-20 |
US20190263859A1 (en) | 2019-08-29 |
TW201936577A (en) | 2019-09-16 |
KR20190103986A (en) | 2019-09-05 |
US11739120B2 (en) | 2023-08-29 |
PH12020551233A1 (en) | 2021-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276917A (en) | Process for the preparation of elobixibat | |
GB2571696B (en) | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced | |
SG11201708516YA (en) | Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells | |
PT3580219T (en) | Process for the preparation of remimazolam and solid state forms of remimazolam salts | |
EP3621613A4 (en) | Aminopyridine compounds and methods for the preparation and use thereof | |
EP3349040A4 (en) | Method for positioning underwater objects and system for the implementation thereof | |
PT3594199T (en) | Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof | |
KR102426307B9 (en) | Bipoolar ion-exchange membrane and method for preparing the same | |
SG11202007544RA (en) | Water soluble salts of lipidated peptides and methods for preparing and using the same | |
LT3765440T (en) | Process for the preparation of n-alkyl-nitratoethylnitramines | |
EP4081028A4 (en) | Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same | |
PL3538029T3 (en) | Joint implant for new tissue formation at the joint | |
EP3837239A4 (en) | Process for the preparation of solriamfetol and salt thereof | |
SI3620452T1 (en) | Process for the preparation of lenvatinib | |
EP3645548C0 (en) | Methods for preparing bile acids | |
RS60451B1 (en) | New processes for the preparation of vemurafenib | |
IL282108A (en) | Preparation method for efinaconazole | |
IL279410A (en) | Process for the preparation of quinmerac | |
IL276861A (en) | Systems and methods for the preparation of plant derived products using osmosis techniques | |
EP3877361C0 (en) | Process for the preparation of arylsulfonylpropenenitriles | |
DK3770165T3 (en) | POSACONAZOL PHOSPHATE ESTER MONOCHOLINE SALT, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | |
PL3599256T3 (en) | Process for the preparation of polyorganosiloaxnes | |
SG11201911987XA (en) | Pure water preparation method and device | |
SI3565602T1 (en) | Novel process for preparing water soluble forskolin | |
EP3515800A4 (en) | Pivoting sea anchor system |